How mRNA therapeutics are entering the monoclonal antibody field

Overview of attention for article published in Journal of Translational Medicine, February 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 65 X posts from 55 X users, with an upper bound of 162,149 followers.

@kalashnikity @HouseLyndsey @benetiq @lasikeyecenter1 @Arch_angel_19 @AGHuff @DocAhmadMalik @ichudov Isn't that similar reason that mABs/nibs/iMids biologics create adverse side effects & events more deadly than the disease they are suppose to treat? h

RT @BeanMimosa: “mRNA encoding Abs … can circumvent problems of complex production + purification processes + aberrant posttranslational mo…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 61 additional X posts.